Evidence map›Paper›PMID 31938129›Full record

ArticleInternational journal of clinical and experimental pathology2018

Associations of miR-605 rs2043556 polymorphism with the susceptibility and overall survival of lung cancer in Chinese non-smoking females.

Xin Xu, Zhihua Yin, Yangwu Ren, Peng Guan, Baosen Zhou

Abstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xin XuDepartment of Clinical Epidemiology and Center of Evidence-Based Medicine, The First Hospital of China Medical University Shenyang, Liaoning, People's Republic of China.
Zhihua YinKey Laboratory of Cancer Etiology and Intervention, University of Liaoning Province Shenyang, Liaoning, People's Republic of China.
Yangwu RenKey Laboratory of Cancer Etiology and Intervention, University of Liaoning Province Shenyang, Liaoning, People's Republic of China.
Peng GuanKey Laboratory of Cancer Etiology and Intervention, University of Liaoning Province Shenyang, Liaoning, People's Republic of China.
Baosen ZhouDepartment of Clinical Epidemiology and Center of Evidence-Based Medicine, The First Hospital of China Medical University Shenyang, Liaoning, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The effects of miR-605 rs2043556 single nucleotide polymorphism (SNP) on the risk and prognosis of lung cancer are unclear. This study investigated the relationships between miR-605 rs2043556 and the susceptibility and overall survival (OS) of lung cancer in Chinese non-smoking females. This hospital-based case-control study included 450 cases and 450 controls. Also, a prospective cohort study was carried out, and the patients were followed up until February 29th, 2016. There were 334 patients with prognostic information. Odds ratio and hazard ratio (HR) and their 95% confidence intervals (CIs) were calculated, respectively. In squamous cell carcinomas (SqCC) patients, homozygous GG genotype carriers had a 2.157-fold elevated risk of lung cancer compared with homozygous AA genotype carriers after adjusting age (95% CI = 1.029-4.524,

Indexed as

Lung cancermicroRNAoverall survivalsingle nucleotide polymorphismsusceptibility

Identifiers

PMID31938129
PMCPMC6957935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.